{"id":563792,"date":"2026-08-26T04:00:00","date_gmt":"2026-08-26T02:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/first-class-immunomodulation-combined-with-convenience-the-data-available-so-far-is-convincing\/"},"modified":"2026-08-31T16:33:48","modified_gmt":"2026-08-31T14:33:48","slug":"first-class-immunomodulation-combined-with-convenience-the-data-available-so-far-is-convincing","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/first-class-immunomodulation-combined-with-convenience-the-data-available-so-far-is-convincing\/","title":{"rendered":"First-class immunomodulation combined with convenience\u2014the data available so far is convincing"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Our understanding of the pathophysiology of psoriasis has improved significantly in recent years, and numerous therapeutic targets have been identified. This has recently led to the development of innovative active ingredients in oral formulations, with zasocitinib\u2014a TYK2 inhibitor\u2014and icotrokinra\u2014an oral peptide that selectively inhibits the interleukin-23 receptor (IL-23)\u2014deserve special mention.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Ffirst-class-immunomodulation-combined-with-convenience-the-data-available-so-far-is-convincing%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Our understanding of the pathophysiology of psoriasis has improved significantly in recent years, and numerous therapeutic targets have been identified. This has recently led to the development of innovative active&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Ffirst-class-immunomodulation-combined-with-convenience-the-data-available-so-far-is-convincing%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":563795,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11513,11340,11480,11503],"tags":[95007,99990,84534,20100,99991,84532,14032,95011],"powerkit_post_featured":[],"class_list":["post-563792","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-congress-reports","category-dermatology-and-venereology","category-rheumatology","category-studies","tag-convenience","tag-iconic-total","tag-icotrokinra-en","tag-immunomodulation","tag-latitude-pso-3001-3002","tag-oral-peptide","tag-psoriasis-en-2","tag-zasocitinib","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-08 11:04:31","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":563814,"slug":"une-immunomodulation-de-premier-ordre-alliee-a-la-praticite-les-donnees-disponibles-a-ce-jour-sont-convaincantes","post_title":"Une immunomodulation de premier ordre alli\u00e9e \u00e0 la praticit\u00e9 : les donn\u00e9es disponibles \u00e0 ce jour sont convaincantes","href":"https:\/\/medizinonline.com\/fr\/une-immunomodulation-de-premier-ordre-alliee-a-la-praticite-les-donnees-disponibles-a-ce-jour-sont-convaincantes\/"},"it_IT":{"locale":"it_IT","id":563822,"slug":"immunomodulazione-di-primordine-unita-alla-praticita-i-dati-disponibili-finora-sono-convincenti","post_title":"Immunomodulazione di prim\u2019ordine unita alla praticit\u00e0: i dati disponibili finora sono convincenti","href":"https:\/\/medizinonline.com\/it\/immunomodulazione-di-primordine-unita-alla-praticita-i-dati-disponibili-finora-sono-convincenti\/"},"pt_PT":{"locale":"pt_PT","id":563831,"slug":"imunomodulacao-de-primeira-classe-aliada-a-praticabilidade-os-dados-disponiveis-ate-ao-momento-sao-convincentes","post_title":"Imunomodula\u00e7\u00e3o de primeira classe aliada \u00e0 praticabilidade \u2013 os dados dispon\u00edveis at\u00e9 ao momento s\u00e3o convincentes","href":"https:\/\/medizinonline.com\/pt-pt\/imunomodulacao-de-primeira-classe-aliada-a-praticabilidade-os-dados-disponiveis-ate-ao-momento-sao-convincentes\/"},"es_ES":{"locale":"es_ES","id":563806,"slug":"una-combinacion-de-inmunomodulacion-de-primera-clase-y-comodidad-los-datos-disponibles-hasta-la-fecha-son-convincentes","post_title":"Una combinaci\u00f3n de inmunomodulaci\u00f3n de primera clase y comodidad: los datos disponibles hasta la fecha son convincentes","href":"https:\/\/medizinonline.com\/es\/una-combinacion-de-inmunomodulacion-de-primera-clase-y-comodidad-los-datos-disponibles-hasta-la-fecha-son-convincentes\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/563792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=563792"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/563792\/revisions"}],"predecessor-version":[{"id":563799,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/563792\/revisions\/563799"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/563795"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=563792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=563792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=563792"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=563792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}